Acute Rejection and Chronic Lung Allograft Dysfunction: Obstructive and Restrictive Allograft Dysfunction

Clin Chest Med. 2023 Mar;44(1):137-157. doi: 10.1016/j.ccm.2022.10.011.

Abstract

Lung transplantation is an established treatment of well-selected patients with end-stage respiratory diseases. However, lung transplant recipients have the highest rates of acute and chronic rejection among transplanted solid organs. Owing to ongoing alloimmune recognition and associated immune-driven airway/vascular remodeling, precipitated by multifactorial, endogenous or exogenous, post-transplant injuries to the bronchovascular axis of the secondary pulmonary lobule, most lung transplant recipients will suffer from a pathophysiological decline of their allograft, either functionally and/or structurally. This review discusses current knowledge, barriers, and gaps in acute cellular rejection and chronic lung allograft dysfunction-the greatest impediment to long-term post-transplant survival.

Keywords: Acute cellular rejection; Bronchiolitis obliterans syndrome; Chronic lung allograft dysfunction; Lung transplantation; Restrictive allograft syndrome; T-cell-mediated rejection.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Allografts
  • Bronchiolitis Obliterans* / etiology
  • Humans
  • Lung
  • Lung Transplantation* / adverse effects
  • Transplantation, Homologous / adverse effects